Azura Ophthalmics nets $20m
Azura Ophthalmics Ltd, an Israeli developer of therapies for Meibomian gland dysfunction and related eye diseases, has raised $20 million in financing.
Azura Ophthalmics Ltd, an Israeli developer of therapies for Meibomian gland dysfunction and related eye diseases, has raised $20 million in financing.
Copyright PEI Media
Not for publication, email or dissemination